(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

YARGESA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

YARGESA

ST13

US500000097221004

Class

5

Filing

97221004

Registration

7444083

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

07/09/2024

Trademark type

Word

Nice classes

5

Filing date

01/14/2022

Registration date

07/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2024

Last transaction

07/09/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/23/2024

First use in commerce

04/23/2024

Drawing code

4

Owner type

16

Owner location

Parsippany, NJ

Examiner

SHIH, SALLY

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Edenbridge Pharmaceuticals, LLC

Representatives

Daniel Gary Worley Jr.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for lysosomal storage disorders

Publications

History of USPTO decisions and trademark events.

33 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/03/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/03/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/18/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/17/2024

IUAF

USE AMENDMENT FILED

04/24/2024

EISU

TEAS STATEMENT OF USE RECEIVED

04/24/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/21/2024

EX3G

SOU EXTENSION 3 GRANTED

02/20/2024

EXT3

SOU EXTENSION 3 FILED

02/20/2024

EEXT

SOU TEAS EXTENSION RECEIVED

02/20/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/23/2023

EX2G

SOU EXTENSION 2 GRANTED

08/21/2023

EXT2

SOU EXTENSION 2 FILED

08/21/2023

EEXT

SOU TEAS EXTENSION RECEIVED

08/21/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/24/2023

EX1G

SOU EXTENSION 1 GRANTED

02/22/2023

EXT1

SOU EXTENSION 1 FILED

02/22/2023

EEXT

SOU TEAS EXTENSION RECEIVED

02/22/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/23/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2022

PUBO

PUBLISHED FOR OPPOSITION

06/28/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2022

ALIE

ASSIGNED TO LIE

05/17/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/12/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

05/12/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/12/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

05/12/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/12/2022

DOCK

ASSIGNED TO EXAMINER

05/11/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/21/2022

NWAP

NEW APPLICATION ENTERED

01/18/2022

Continuous trademark protection

Get notified about every new filing that threatens YARGESA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.